| 000 | 01808 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250516173919.0 | ||
| 264 | 0 | _c20150126 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1365-2893 | ||
| 024 | 7 |
_a10.1111/jvh.12177 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Q | |
| 245 | 0 | 0 |
_aIFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients. _h[electronic resource] |
| 260 |
_bJournal of viral hepatitis _cJul 2014 |
||
| 300 |
_a525-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xclassification |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aInterferons |
| 650 | 0 | 4 |
_aInterleukins _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLapalus, M | |
| 700 | 1 | _aAsselah, T | |
| 700 | 1 | _aLaouénan, C | |
| 700 | 1 | _aMoucari, R | |
| 700 | 1 | _aMartinot-Peignoux, M | |
| 700 | 1 | _aBieche, I | |
| 700 | 1 | _aEstrabaud, E | |
| 700 | 1 | _aDe Muynck, S | |
| 700 | 1 | _aBoyer, N | |
| 700 | 1 | _aBedossa, P | |
| 700 | 1 | _aVidaud, M | |
| 700 | 1 | _aMarcellin, P | |
| 700 | 1 | _aLada, O | |
| 773 | 0 |
_tJournal of viral hepatitis _gvol. 21 _gno. 7 _gp. 525-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jvh.12177 _zAvailable from publisher's website |
| 999 |
_c23164418 _d23164418 |
||